FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely therapy, and concerns treating fibrotic diseases. That is ensured by administering 40-O-(2-hydroxy)ethylrapamycin or a pharmaceutical composition thereof in the effective amount.
EFFECT: administering the above compound provides slowing of the hepatic fibrosis development, including following liver transplantation with underlying immunosuppressive therapy.
3 cl
| Title | Year | Author | Number |
|---|---|---|---|
| RAPAMYCIN DERIVATIVE OR IMPDH INHIBITOR FOR TREATING POLYCYSTIC KIDNEY DISEASE | 2006 |
|
RU2491933C2 |
| TREATING NEUROENDOCRINE TUMOURS | 2006 |
|
RU2487711C2 |
| COMBINATION AND METHOD FOR PROPHYLAXIS OF BREAST CANCER | 2002 |
|
RU2322981C2 |
| TREATING TUBEROUS SCLEROSIS | 2007 |
|
RU2473343C2 |
| COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND mTOR KINASE INHIBITOR | 2006 |
|
RU2443418C2 |
| RAPAMYCIN DERIVATIVES | 2018 |
|
RU2807188C2 |
| MIF INHIBITORS | 2005 |
|
RU2383541C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS APPLICABLE FOR TREATING CANCER | 2007 |
|
RU2447891C2 |
| PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2159107C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2659725C2 |
